The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2017

Filed:

Dec. 11, 2015
Applicants:

Alectos Therapeutics Inc., Burnaby, CA;

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Ramesh Kaul, Burnaby, CA;

Ernest J. McEachern, Burnaby, CA;

Changwei Mu, Beijing, CN;

Harold G. Selnick, West Point, PA (US);

David J. Vocadlo, Burnaby, CA;

Yaode Wang, Beijing, CN;

Zhongyong Wei, Beijing, CN;

Yuanxi Zhou, Burnaby, CA;

Yongbao Zhu, Burnaby, CA;

Assignees:

Alectos Therapeutics, Inc., Burnaby, CA;

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 9/06 (2006.01); C07H 9/00 (2006.01); C07D 513/04 (2006.01); C12Q 1/34 (2006.01); C07H 17/00 (2006.01);
U.S. Cl.
CPC ...
C07H 9/06 (2013.01); C07D 513/04 (2013.01); C07H 9/00 (2013.01); C07H 17/00 (2013.01); C12Q 1/34 (2013.01); G01N 2333/924 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract

The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.


Find Patent Forward Citations

Loading…